The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Liposomes Drug Delivery Market Research Report 2024

Global Liposomes Drug Delivery Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1705472

No of Pages : 90

Synopsis
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market was valued at US$ 3335.2 million in 2023 and is anticipated to reach US$ 6549.6 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
This report aims to provide a comprehensive presentation of the global market for Liposomes Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Drug Delivery.
Report Scope
The Liposomes Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposomes Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposomes Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Liposomes Drug Delivery Market Overview
1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Liposomes Drug Delivery Segment by Type
1.2.1 Global Liposomes Drug Delivery Market Value Comparison by Type (2024-2030)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery Segment by Application
1.3.1 Global Liposomes Drug Delivery Market Value by Application: (2024-2030)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposomes Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposomes Drug Delivery Revenue 2019-2030
1.4.2 Global Liposomes Drug Delivery Sales 2019-2030
1.4.3 Global Liposomes Drug Delivery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Liposomes Drug Delivery Market Competition by Manufacturers
2.1 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Liposomes Drug Delivery Average Price by Manufacturers (2019-2024)
2.4 Global Liposomes Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomes Drug Delivery, Product Type & Application
2.7 Liposomes Drug Delivery Market Competitive Situation and Trends
2.7.1 Liposomes Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liposomes Drug Delivery Players Market Share by Revenue
2.7.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liposomes Drug Delivery Retrospective Market Scenario by Region
3.1 Global Liposomes Drug Delivery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Liposomes Drug Delivery Global Liposomes Drug Delivery Sales by Region: 2019-2030
3.2.1 Global Liposomes Drug Delivery Sales by Region: 2019-2024
3.2.2 Global Liposomes Drug Delivery Sales by Region: 2025-2030
3.3 Global Liposomes Drug Delivery Global Liposomes Drug Delivery Revenue by Region: 2019-2030
3.3.1 Global Liposomes Drug Delivery Revenue by Region: 2019-2024
3.3.2 Global Liposomes Drug Delivery Revenue by Region: 2025-2030
3.4 North America Liposomes Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposomes Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Liposomes Drug Delivery Sales by Country (2019-2030)
3.4.3 North America Liposomes Drug Delivery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liposomes Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposomes Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Liposomes Drug Delivery Sales by Country (2019-2030)
3.5.3 Europe Liposomes Drug Delivery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomes Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Liposomes Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Liposomes Drug Delivery Sales by Country (2019-2030)
3.6.3 Asia Pacific Liposomes Drug Delivery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposomes Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Liposomes Drug Delivery Sales by Country (2019-2030)
3.7.3 Latin America Liposomes Drug Delivery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomes Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Liposomes Drug Delivery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomes Drug Delivery Sales by Type (2019-2030)
4.1.1 Global Liposomes Drug Delivery Sales by Type (2019-2024)
4.1.2 Global Liposomes Drug Delivery Sales by Type (2025-2030)
4.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2019-2030)
4.2 Global Liposomes Drug Delivery Revenue by Type (2019-2030)
4.2.1 Global Liposomes Drug Delivery Revenue by Type (2019-2024)
4.2.2 Global Liposomes Drug Delivery Revenue by Type (2025-2030)
4.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2019-2030)
4.3 Global Liposomes Drug Delivery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Liposomes Drug Delivery Sales by Application (2019-2030)
5.1.1 Global Liposomes Drug Delivery Sales by Application (2019-2024)
5.1.2 Global Liposomes Drug Delivery Sales by Application (2025-2030)
5.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2019-2030)
5.2 Global Liposomes Drug Delivery Revenue by Application (2019-2030)
5.2.1 Global Liposomes Drug Delivery Revenue by Application (2019-2024)
5.2.2 Global Liposomes Drug Delivery Revenue by Application (2025-2030)
5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2019-2030)
5.3 Global Liposomes Drug Delivery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Liposomes Drug Delivery Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gilead Sciences Liposomes Drug Delivery Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Pacira
6.3.1 Pacira Corporation Information
6.3.2 Pacira Description and Business Overview
6.3.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pacira Liposomes Drug Delivery Product Portfolio
6.3.5 Pacira Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Liposomes Drug Delivery Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Luye Pharma
6.5.1 Luye Pharma Corporation Information
6.5.2 Luye Pharma Description and Business Overview
6.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Liposomes Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments/Updates
6.6 Sigma-Tau Group
6.6.1 Sigma-Tau Group Corporation Information
6.6.2 Sigma-Tau Group Description and Business Overview
6.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sigma-Tau Group Liposomes Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Group Recent Developments/Updates
6.7 Fudan-Zhangjiang
6.6.1 Fudan-Zhangjiang Corporation Information
6.6.2 Fudan-Zhangjiang Description and Business Overview
6.6.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolio
6.7.5 Fudan-Zhangjiang Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Liposomes Drug Delivery Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 CSPC
6.9.1 CSPC Corporation Information
6.9.2 CSPC Description and Business Overview
6.9.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSPC Liposomes Drug Delivery Product Portfolio
6.9.5 CSPC Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Liposomes Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Kingond Pharm
6.11.1 Kingond Pharm Corporation Information
6.11.2 Kingond Pharm Liposomes Drug Delivery Description and Business Overview
6.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kingond Pharm Liposomes Drug Delivery Product Portfolio
6.11.5 Kingond Pharm Recent Developments/Updates
6.12 Spectrum Pharmaceuticals
6.12.1 Spectrum Pharmaceuticals Corporation Information
6.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Description and Business Overview
6.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolio
6.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.13 Shanghai New Asia
6.13.1 Shanghai New Asia Corporation Information
6.13.2 Shanghai New Asia Liposomes Drug Delivery Description and Business Overview
6.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai New Asia Liposomes Drug Delivery Product Portfolio
6.13.5 Shanghai New Asia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomes Drug Delivery Industry Chain Analysis
7.2 Liposomes Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomes Drug Delivery Production Mode & Process
7.4 Liposomes Drug Delivery Sales and Marketing
7.4.1 Liposomes Drug Delivery Sales Channels
7.4.2 Liposomes Drug Delivery Distributors
7.5 Liposomes Drug Delivery Customers
8 Liposomes Drug Delivery Market Dynamics
8.1 Liposomes Drug Delivery Industry Trends
8.2 Liposomes Drug Delivery Market Drivers
8.3 Liposomes Drug Delivery Market Challenges
8.4 Liposomes Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’